COLORADO INSTITUTE FOR DRUG DEVICE AND DIAGNOSTIC DEVELOPMENT (EIN 264629200) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2009

Legal Domicile

Principal Officer

RICHARD C DUKE PHD

Phone

7202555722

Tax Period

2021-07-01 to 2022-06-30

COLORADO INSTITUTE FOR DRUG DEVICE AND DIAGNOSTIC DEVELOPMENT, founded in 2009, is a micro nonprofit that reported $12K in total revenue in fiscal year 2021. Revenue fell 44% from the prior year — a significant decline worth monitoring. Expenses of $1.6M exceeded revenue, resulting in a 13536% operating deficit.

Mission

THE ORGANIZATION HAS BEEN FORMED FOR THE PURPOSE OF EXPANDING LIFE SCIENCE INDUSTRY IN THE STATE OF COLORADO.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2021)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $12,000

Other Revenue $0

TOTAL REVENUE $12,000

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $1,614,914

Other Expenses $1,636,379

TOTAL EXPENSES $1,636,379

Year-over-Year Comparison

	2021	2020	Change
Revenue	$12,000	$21,500	-0.4%
Expenses	$1,636,379	$12,072	+134.6%
Net Income	$-1,624,379	$9,428	-173.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
RICHARD C DUKE PHD	CSO/SECRETAR	1.00	Officer Director	$0	$0	$0
BRUCE EATON PHD	DIRECTOR	1.00	Director	$0	$0	$0
AJAY MENON	DIRECTOR	1.00	Director	$0	$0	$0
MARK LUPA PHD	DIRECTOR	1.00	Director	$0	$0	$0
JONATHAN THORNE	DIRECTOR	1.00	Director	$0	$0	$0
STEVE VANNURDEN	DIRECTOR	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2022	$12,000	$1,636,379	No data	$-1,624,379
2021	$21,500	$12,072	$1,624,379	$9,428
2020	$38,000	$40,664	$1,614,951	$-2,664
2019	$176,289	$138,168	$1,617,615	$38,121
2018	$224,996	$681,918	$1,580,754	$-456,922

COLORADO INSTITUTE FOR DRUG DEVICE AND DIAGNOSTIC DEVELOPMENT